TipRanks
JW LIFESCIENCE CORPORATION (KR:234080)
:234080
South Korea Market
234080
JW LIFESCIENCE CORPORATION
RESEARCH TOOLSreports

JW LIFESCIENCE CORPORATION (234080) Income Statement

― Followers

JW LIFESCIENCE CORPORATION Income Statement

Last quarter (Q2 2026), JW LIFESCIENCE CORPORATION's total revenue was ₩63.25B, an increase of 15.61% from the same quarter last year. In Q2, JW LIFESCIENCE CORPORATION's net income was ₩8.01B. See JW LIFESCIENCE CORPORATION’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 257.83B₩ 222.48B₩ 206.86B₩ 188.93B₩ 169.82B
Gross Profit
₩ 69.77B₩ 57.51B₩ 52.35B₩ 48.12B₩ 49.16B
Operating Expenses
₩ 36.53B₩ 21.65B₩ 21.53B₩ 21.03B₩ 20.74B
Depreciation and Amortization
₩ 18.17B₩ 15.74B₩ 15.53B₩ 14.96B₩ 13.24B
EBITDA
₩ 51.41B₩ 76.82B₩ 50.83B₩ 43.75B₩ 37.59B
Operating Income
₩ 33.30B₩ 35.86B₩ 30.86B₩ 27.09B₩ 28.42B
Other Income/Expenses
₩ -1.50B₩ 23.17B₩ 2.85B₩ -6.31B₩ -10.13B
Pretax Income
₩ 31.75B₩ 59.03B₩ 33.71B₩ 20.78B₩ 18.29B
Net Income
₩ 28.61B₩ 43.99B₩ 28.14B₩ 14.96B₩ 12.91B
Per Share Metrics
Basic EPS
₩ 1.85K₩ 2.84K₩ 1.82K₩ 966.21₩ 828.84
Diluted EPS
₩ 1.85K₩ 2.84K₩ 1.82K₩ 966.21₩ 828.84
Weighted Average Shares Outstanding
 15.45M 15.48M 15.48M 15.48M 15.58M
Weighted Average Shares Outstanding (Diluted)
 15.45M 15.48M 15.48M 15.48M 15.58M
Currency in KRW

JW LIFESCIENCE CORPORATION Earnings and Revenue History